Search Results 261-270 of 16306 for immunothérapie Bylaska

  1. ... IMMUNOTHERAPY,143063.09 MS020,INTRACRANIAL VASCULAR PROCEDURES WITH PRINCIPAL DIAGNOSIS HEMORRHAGE WITH MCC,184437.06 MS021,INTRACRANIAL VASCULAR PROCEDURES ...

  2. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers discover biomarker for predicting immunotherapy response in mesothelioma cancer. Susan Murphy. January 19, 2022. Direct oral ...

  3. Eribulin Mesylate in Treating Patients With Recurrent or Refractory Osteosarcoma - Mayo Clinic

    ... immunotherapy, or radiotherapy prior to entering this study. Myelosuppressive chemotherapy: must not have received within 2 weeks of entry onto this study (6 ...

  4. Radiation Clinical Trials - Mayo Clinic Research

    An effective immunotherapy is one which would induce necrotic cell death and accompanying proinflammatory cytokine induction. Stereotactic Body Radiotherapy ...

  5. Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma - Mayo Clinic

    No concurrent radiotherapy, chemotherapy, or immunotherapy for another active malignancy; Able to receive concurrent prophylactic anticoagulation therapy ...

  6. Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer - Mayo Clinic

    No prior immunotherapy for advanced/metastatic MCC; Patients with known or suspected central nervous system (CNS) metastases, untreated CNS metastases, or ...

  7. Panitumumab (intravenous route) - Side effects & uses - Mayo Clinic

    Panitumumab injection is used alone or in combination with other medicines to treat metastatic cancer (cancer that spreads to other parts of the body) of the ...

  8. Colon Melanoma Clinical Trials - Mayo Clinic Research

    An Investigational Immuno-therapy Study to Assess the Safety, Tolerability ... immunotherapy. NSCLC and melanoma that HAVE previously been treated with ...

  9. A Study to Evaluate Pembrolizumab for Surgically Treated Adjuvant Merkel Cell Carcinoma - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

  10. Radiation Therapy with Durvalumab or Cetuximab to Treat Patients with Locoregionally Advanced Head and Neck Cancer who Cannot Take Cisplatin - Mayo Clinic

    Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Immunotherapy with monoclonal antibodies, such as durvalumab or cetuximab, may ...